betamethasone

What the FDA Data Shows for betamethasone

The FDA label for betamethasone (sold under brand names such as Diprosone, Luxiq) classifies it as a prescription-only medication in the Topical Corticosteroid class. This cream treats skin problems that cause swelling, itching, and redness. Official labeling lists 5 commonly reported side effects, including Stinging (in adults), Skin getting thinner (in children), Spider veins (in children).

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. The database also lists 2 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $0.45.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.